Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
163.11B | 144.15B | 132.09B | 127.48B | 127.03B | Gross Profit |
155.53B | 136.85B | 124.86B | 118.82B | 118.23B | EBIT |
21.06B | 23.72B | 11.24B | 17.53B | 1.68B | EBITDA |
24.98B | 27.32B | 14.66B | 20.90B | 4.70B | Net Income Common Stockholders |
21.82B | 22.34B | 12.33B | 18.44B | 1.39B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
56.92B | 45.79B | 46.76B | 42.65B | 44.98B | Total Assets |
1.27T | 1.07T | 935.64B | 863.35B | 860.51B | Total Debt |
664.90B | 561.24B | 480.40B | 457.64B | 475.89B | Net Debt |
607.99B | 517.98B | 435.95B | 416.69B | 432.37B | Total Liabilities |
1.06T | 890.89B | 779.12B | 715.66B | 731.58B | Stockholders Equity |
197.91B | 176.07B | 153.90B | 145.55B | 126.02B |
Cash Flow | Free Cash Flow | |||
-84.31B | -75.08B | -19.15B | 15.67B | -53.39B | Operating Cash Flow |
-74.21B | -70.59B | -15.63B | 20.28B | -51.13B | Investing Cash Flow |
-12.76B | -8.95B | -2.22B | -9.27B | -2.72B | Financing Cash Flow |
100.93B | 78.20B | 21.03B | -18.81B | 55.36B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | $263.10B | 13.48 | 4.16% | 3.98% | 9.27% | -6.56% | |
71 Outperform | €631.50B | 10.83 | 8.89% | 3.54% | 8.26% | 11.43% | |
64 Neutral | $12.57B | 9.74 | 7.88% | 16985.68% | 12.42% | -5.45% | |
62 Neutral | ¥8.43B | 6.13 | 4.51% | 2.13% | 10.94% | ||
58 Neutral | €174.13B | 7.77 | 10.80% | 0.28% | 15.19% | 12.66% |